In contrast, BCL-xL overexpression has been detected in PC patients and has been associated with shorter patient survival times [98], accelerated PC carcinogenesis, and reduced senescence and apoptosis in PanIN, causing reduced survival time of K-RAS-mutant mice. Here, KRAS is linked to pachyonychia congenita.